🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Study of E. Coli Isolates From Recurrent Urinary Tract Infections

Recruitingn/aAges 18 Years - anyAllUniversité Catholique de Louvain
NCT05826067 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Prospective study aiming at collecting clinical Escherichia coli isolates from patients with recurrent urinary tract infection; samples to be collected during routine procedures.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients hospitalized for urinary tract infection, with or without neurological disorders (spina bifida, MS, paraplegic patients) or ambulatory patients diagnosed with a urinary tract infection when the identified causative agent is E. coli * patients who have or are planned to undergo the insertion of a suprapubic catheter * patients who have or are planned to undergo the insertion a nephrostomy catheter Exclusion Criteria: patients * refusing the planned treatment * with therapy compliance * pregnant women * who do not consent to participate
💊

What it tests

  • collection of bacterial strains
📍

Where

1 site
Cliniques universitaires Saint Luc
Brussels, Belgium
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy